We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£520.00
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
Price data last checked 125 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£520 today · cheaper than every other day in the last 11 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 209 days • 209 data points (No recent data available)
Price Distribution
Price distribution over 209 days • 1 price levels
Price Analysis
Most common price: £520 (209 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 209 days
Product Specifications
- Format
- paperback
- ASIN
- B0BLR1WS99
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 10 November 2022
Similar Products You Might Like
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in India
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in China
The 2025-2030 World Outlook for Neuroendocrine Tumor Treatments
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments for US Zip Codes
Neuroendocrine Tumors: Surgical Evaluation and Management
Springer
Neuroendocrine Tumours: Diagnosis and Management
Springer
Neuroendocrine Neoplasia Management: New Approaches for Diagnosis and Treatment
Springer
The Spectrum of Neuroendocrine Neoplasia: A Practical Approach to Diagnosis, Classification and Therapy
Springer
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India
Neuroendocrine Tumors (Current Clinical Oncology)
Humana
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States
The 2016-2021 Outlook for Nanobiotechnology Solutions in the United States
The 2016-2021 Outlook for Nanomedicine in the United States
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in the United States
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in India
The 2023-2028 Outlook for Healthcare Nutrition in the United States
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in the United States
The 2016-2021 Outlook for Pharmaceutical Preparations for Human Use Affecting Neoplasms, the Endocrine System, and Metabolic Diseases in Japan
